Raymond James analyst John Freeman raised the firm’s price target on Crescent Energy (CRGY) to $17 from $14 and keeps a Strong Buy rating on the shares following Crescent’s agreement to acquire Vital Energy (VTLE) in an all-stock deal. The transaction establishes Crescent as “a top 10 liquids-weighted E&P based on production,” according to the analyst, who is forecasting 2026 production of 375.2 Mboe/d.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRGY:
- Vital Energy moved to No Rating at BofA after Crescent Energy deal
- Crescent Energy falls -4.6%
- Crescent Energy Announces Merger with Vital Energy
- Crescent Energy’s Strategic Acquisitions and Financial Positioning Justify Buy Rating
- Keurig Dr Pepper buys JDE Peet’s, Thoma Bravo to acquire Verint: Morning Buzz